Diosmectite (brand names Smecta, Smecdral) is a natural silicate of aluminium and magnesium used as an intestinal adsorbent in the treatment of several gastrointestinal diseases, including infectious and non-infectious acute and chronic diarrhoea, including irritable bowel syndrome diarrhea subtype. Other uses include: chronic diarrhea caused by radiation-induced, chemotherapy-induced, and HIV/AIDS-associated chronic diarrhea.
This report contains market size and forecasts of Diosmectite For Children in global, including the following market information:
Global Diosmectite For Children Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Diosmectite For Children Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Diosmectite For Children companies in 2021 (%)
The global Diosmectite For Children market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prescription Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diosmectite For Children include Simcere, Ipson, Yangtze River Pharmaceutical Group, Shangdong Hongjitang Pharmaceutical, Conba Pharmaceutical, Harbin Pharmaceutical Group, Luye Pharma Group, ZhuZhou QianJin Pharmaceutical and Zhejiang Hailisheng Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diosmectite For Children manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diosmectite For Children Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Diosmectite For Children Market Segment Percentages, by Type, 2021 (%)
Prescription Drug
Over-the-Counter Drug
Global Diosmectite For Children Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Diosmectite For Children Market Segment Percentages, by Application, 2021 (%)
Bacterial Diarrhea
Viral Diarrhea
Oral Inflammation
Esophagitis
Gastritis
Global Diosmectite For Children Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Diosmectite For Children Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diosmectite For Children revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Diosmectite For Children revenues share in global market, 2021 (%)
Key companies Diosmectite For Children sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Diosmectite For Children sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Simcere
Ipson
Yangtze River Pharmaceutical Group
Shangdong Hongjitang Pharmaceutical
Conba Pharmaceutical
Harbin Pharmaceutical Group
Luye Pharma Group
ZhuZhou QianJin Pharmaceutical
Zhejiang Hailisheng Pharmaceutical
Hanmi Pharmaceutical
Lukang Pharmaceutical
China Resources Double-crane Pharmaceutical
Honz Pharmaceutical
Siromed
Salvat
Bliss GVS Pharma
Weiao Pharmaceuticals